XENOVIEW (XENON XE-129 HYPERPOLARIZED) — FDA Approval NDA214375 (POLAREAN)
XENOVIEW (XENON XE-129 HYPERPOLARIZED) — FDA Approval NDA214375 (POLAREAN) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: XENOVIEW; Active ingredients: XENON XE-129 HYPERPOLARIZED; Application number: NDA214375.
| Brand name | XENOVIEW |
|---|---|
| Active ingredients | XENON XE-129 HYPERPOLARIZED |
| Application number | NDA214375 |
| Sponsor | POLAREAN |
| Dosage form | GAS |
| Route | INHALATION |
| Marketing status | Prescription |
| Products in application | 1 |
| First approval date | 20221223 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →